Cargando…
The impact of adjuvant radiotherapy on molecular prognostic markers in gliomas
PURPOSE: Changes in MGMT promoter methylation, IDH1 and IDH2 mutation, and 1p/19q co-deletion status in gliomas between first and subsequent resections and their associated clinical factors are poorly described. In this study, we assayed these biomarkers in the clinical setting. PATIENTS AND METHODS...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441459/ https://www.ncbi.nlm.nih.gov/pubmed/30988626 http://dx.doi.org/10.2147/OTT.S200818 |